BDR-167

N/A

Report date: 2023/08/01 09:47:01
NME

Base Information

Drug NameBDR-167
Drug Alias NameBDR-167
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMDimune IncNeoCura Bio Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMDimune Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A